Industry Outlook
The global genomics market held US$ 18,964.2 Mn in 2020 and expected to grow at compound annual growth rate (CAGR) of 10.4% during the forecast period from 2022 to 2030. The exploration of genomics has surpassed in the last three decades to massive advancements in the technology that allowed the researchers to sequence larger pieces of genome. Polymerase chain reaction (PCR) techniques, microarray and next-generation sequencing have made the whole genome sequencing cost effective and highly efficient. These advancements in the technology has assisted in the various fields of applied biology such as clinical genomics, discovery and development of novel drugs and personalized medicine for various chronic diseases. For instance, genomics have revolutionized point-of-care testing across various infectious diseases, cancer and congenital ailments enabling analysis of novel analytes, broad spectrum analytical performances and better turnaround time. Various biotechnology companies have ventured in the market of genomics changing the dynamics of the market. In 2003, the cost of sequencing of human genome of approximately US$ 3 billion. However, launch of highly advanced next-generation sequencing products by Illumina, Inc., have significantly decreased the cost of human genome sequencing to US$ 1,000. Thus, dramatic decrease in the cost of sequencing and growing investments in biopharmaceutical research have driven the growth of global genomics market. Projects such as Human Genome Project, Saudi Human Genome Program (SHGP), and U.K. 100,000 Genome Projects are further projected to drive the market for genomics worldwide. However, huge investment and research infrastructure required for genomics research are some of the major restraining factor for the growth of this market.Increased Adoption of NGS to Drive the Genomics Market
In 2021, products segment held the largest share in the global genomics market. The product segment is further segmented in instrumentation technology and consumables/reagents sub-segment. The instrumentation technology segment is projected to grow at a significant rate during the forecast period owing to high adoption of NGS platforms. Simplified workflow on NGS, significant reduction in costs of NGS instruments and reagents, and growing implementation of NGS in clinical application such as oncology, genetic studies, and reproductive health will further drive the market during the forecast period. With the advent of microarrays and microfluidics in point-of-care diagnostics and advancements in PCR and nucleic acid amplification technologies in DNA sequencing will further drive the market.North America Dominated the Global Genomics Market
In 2021, North America held the largest share in the global genomics market owing to huge investments on genomic research by government institutions, growing awareness regarding genetic analysis such as direct-to-consumer genetic testing, non-invasive prenatal testing and other genetic testing in the region. Moreover, growing number of budding biotechnology companies offering various genetic testing services in the region and presence of major biopharmaceutical giants in the region further make North America the most lucrative market in the global genomics market. Asia Pacific is projected to witness fastest growth during the forecast period owing to increasing genetic R&D activities, growing healthcare infrastructure focusing of genomic studies for drug discovery and disease treatment. Moreover, reducing cost of genomics services and foreign investments in the region further drive the growth of market.Market is studied in order to understand the current dynamics and future trends in the global genomics market. The study includes market size and forecast for all considered segments presented in the report for the period from 2020 to 2030, along with respective compound annual growth rate (CAGRs) for the forecast period from 2022 to 2030, considering 2020 as the base year. The key players currently engaged in genomics market include Thermo Fisher Scientific, Inc., Bio-Rad Technologies, Inc., Illumina, Inc., Danaher Corporation, BGI, Pacific Biosciences, Oxford Nanopore Technologies., Myriad Genetics, Inc., among others. The companies are engaged in launch of novel products and tools to maintain their position in the market. Mergers & acquisitions are an important growth strategy undertaken in the industry to keep a competitive edge in the market. For instance, Thermo Fisher Scientific acquired Life Technologies in 2019 to become the market leader in the genomics market.
Historical & Forecast Period
This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Genomics market are as follows:- Research and development budgets of manufacturers and government spending
- Revenues of key companies in the market segment
- Number of end users and consumption volume, price and value.
- Geographical revenues generate by countries considered in the report
- Micro and macro environment factors that are currently influencing the Genomics market and their expected impact during the forecast period.
Market Segmentation
Product & Services
- Products
- Instrumentation Technology
- Sequencing Technology
- Microarray
- Polymerase Chain Reaction (PCR)
- Nucleic Acid Extraction and Purification
- Other Technologies
- Consumables/Reagents
- Services
- Genomic Services
- Sequencing Services
- Data Analysis
End-User
- Academic and Government Research
- Hospitals & Clinics
- Biopharmaceutical Companies
- Clinical Research
Key questions answered in this report
- What are the key micro and macro environmental factors that are impacting the growth of Genomics market?
- What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
- Estimated forecast and market projections up to 2030.
- Which segment accounts for the fastest CAGR during the forecast period?
- Which market segment holds a larger market share and why?
- Are low and middle-income economies investing in the Genomics market?
- Which is the largest regional market for Genomics market?
- What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
- Which are the key trends driving Genomics market growth?
- Who are the key competitors and what are their key strategies to enhance their market presence in the Genomics market worldwide?
This product will be delivered within 2 business days.
Table of Contents
1. Preface1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Genomics Market
2.2. Global Genomics Market, By Product & Services, 2021 (US$ Million)
2.3. Global Genomics Market, By End-User, 2021 (US$ Million)
2.4. Global Genomics Market, By Geography, 2021 (US$ Million)
2.5. Attractive Investment Proposition by Geography, 2021
3. Genomics Market: Competitive Analysis
3.1. Market Positioning of Key Genomics Market Vendors
3.2. Strategies Adopted by Genomics Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2021 Versus 2030
4. Genomics Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Genomics Market Value, 2020 - 2030, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Genomics Market: By Product & Services, 2020-2030, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2021 Versus 2030
5.3. Market Segmentation
5.3.1. Products
5.3.1.1. Instrumentation Technology
5.3.1.1.1. Sequencing Technology
5.3.1.1.2. Microarray
5.3.1.1.3. Polymerase Chain Reaction (PCR)
5.3.1.1.4. Nucleic Acid Extraction and Purification
5.3.1.1.5. Other Technologies
5.3.1.2. Consumables/Reagents
5.3.2. Services
5.3.2.1. Genomic Services
5.3.2.2. Sequencing Services
5.3.2.3. Data Analysis
6. Genomics Market: By End-User, 2020-2030, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2021 Versus 2030
6.3. Market Segmentation
6.3.1. Academic and Government Research
6.3.2. Hospitals & Clinics
6.3.3. Biopharmaceutical Companies
6.3.4. Clinical Research
7. North America Genomics Market, 2020-2030, USD (Million)
7.1. Market Overview
7.2. Genomics Market: By Product & Services, 2020-2030, USD (Million)
7.3. Genomics Market: By End-User, 2020-2030, USD (Million)
7.4.Genomics Market: By Region, 2020-2030, USD (Million)
7.4.1.North America
7.4.1.1. U.S.
7.4.1.1.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
7.4.1.1.1. Genomics Market: By End-User, 2020-2030, USD (Million)
7.4.1.2. Canada
7.4.1.2.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
7.4.1.2.1. Genomics Market: By End-User, 2020-2030, USD (Million)
7.4.1.3. Rest of North America
7.4.1.3.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
7.4.1.3.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8. UK and European Union Genomics Market, 2020-2030, USD (Million)
8.1. Market Overview
8.2. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.3. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.Genomics Market: By Region, 2020-2030, USD (Million)
8.4.1.UK and European Union
8.4.1.1. UK
8.4.1.1.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.1.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.1.2. Germany
8.4.1.2.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.2.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.1.3. Spain
8.4.1.3.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.3.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.1.4. Italy
8.4.1.4.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.4.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.1.5. France
8.4.1.5.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.5.1. Genomics Market: By End-User, 2020-2030, USD (Million)
8.4.1.6. Rest of Europe
8.4.1.6.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
8.4.1.6.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9. Asia Pacific Genomics Market, 2020-2030, USD (Million)
9.1. Market Overview
9.2. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.3. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.Genomics Market: By Region, 2020-2030, USD (Million)
9.4.1.Asia Pacific
9.4.1.1. China
9.4.1.1.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.1.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.1.2. Japan
9.4.1.2.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.2.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.1.3. India
9.4.1.3.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.3.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.1.4. Australia
9.4.1.4.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.4.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.1.5. South Korea
9.4.1.5.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.5.1. Genomics Market: By End-User, 2020-2030, USD (Million)
9.4.1.6. Rest of Asia Pacific
9.4.1.6.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
9.4.1.6.1. Genomics Market: By End-User, 2020-2030, USD (Million)
10. Latin America Genomics Market, 2020-2030, USD (Million)
10.1. Market Overview
10.2. Genomics Market: By Product & Services, 2020-2030, USD (Million)
10.3. Genomics Market: By End-User, 2020-2030, USD (Million)
10.4.Genomics Market: By Region, 2020-2030, USD (Million)
10.4.1.Latin America
10.4.1.1. Brazil
10.4.1.1.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
10.4.1.1.1. Genomics Market: By End-User, 2020-2030, USD (Million)
10.4.1.2. Mexico
10.4.1.2.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
10.4.1.2.1. Genomics Market: By End-User, 2020-2030, USD (Million)
10.4.1.3. Rest of Latin America
10.4.1.3.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
10.4.1.3.1. Genomics Market: By End-User, 2020-2030, USD (Million)
11. Middle East and Africa Genomics Market, 2020-2030, USD (Million)
11.1. Market Overview
11.2. Genomics Market: By Product & Services, 2020-2030, USD (Million)
11.3. Genomics Market: By End-User, 2020-2030, USD (Million)
11.4.Genomics Market: By Region, 2020-2030, USD (Million)
11.4.1.Middle East and Africa
11.4.1.1. GCC
11.4.1.1.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
11.4.1.1.1. Genomics Market: By End-User, 2020-2030, USD (Million)
11.4.1.2. Africa
11.4.1.2.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
11.4.1.2.1. Genomics Market: By End-User, 2020-2030, USD (Million)
11.4.1.3. Rest of Middle East and Africa
11.4.1.3.1. Genomics Market: By Product & Services, 2020-2030, USD (Million)
11.4.1.3.1. Genomics Market: By End-User, 2020-2030, USD (Million)
12. Company Profile
12.1. Thermo Fisher Scientific, Inc.
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Portfolio
12.1.4. Strategic Initiatives
12.2. Agilent Technologies, Inc.
12.2.1. Company Overview
12.2.2. Financial Performance
12.2.3. Product Portfolio
12.2.4. Strategic Initiatives
12.3. Bio-Rad Laboratories, Inc.
12.3.1. Company Overview
12.3.2. Financial Performance
12.3.3. Product Portfolio
12.3.4. Strategic Initiatives
12.4. Merck KGaA
12.4.1. Company Overview
12.4.2. Financial Performance
12.4.3. Product Portfolio
12.4.4. Strategic Initiatives
12.5. Danaher Corporation
12.5.1. Company Overview
12.5.2. Financial Performance
12.5.3. Product Portfolio
12.5.4. Strategic Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Financial Performance
12.6.3. Product Portfolio
12.6.4. Strategic Initiatives
12.7. BGI
12.7.1. Company Overview
12.7.2. Financial Performance
12.7.3. Product Portfolio
12.7.4. Strategic Initiatives
12.8. Illumina, Inc.
12.8.1. Company Overview
12.8.2. Financial Performance
12.8.3. Product Portfolio
12.8.4. Strategic Initiatives
12.9. Oxford Nanopore Technologies
12.9.1. Company Overview
12.9.2. Financial Performance
12.9.3. Product Portfolio
12.9.4. Strategic Initiatives
12.10. Pacific Biosciences of California, Inc.
12.10.1. Company Overview
12.10.2. Financial Performance
12.10.3. Product Portfolio
12.10.4. Strategic Initiatives
12.11. QIAGEN
12.11.1. Company Overview
12.11.2. Financial Performance
12.11.3. Product Portfolio
12.11.4. Strategic Initiatives
12.12. Myriad Genetics, Inc.
12.12.1. Company Overview
12.12.2. Financial Performance
12.12.3. Product Portfolio
12.12.4. Strategic Initiatives
12.13. Eurofins Scientific
12.13.1. Company Overview
12.13.2. Financial Performance
12.13.3. Product Portfolio
12.13.4. Strategic Initiatives
12.14. 23nMe, Inc.
12.14.1. Company Overview
12.14.2. Financial Performance
12.14.3. Product Portfolio
12.14.4. Strategic Initiatives
List of Figures
Figure 1 Global Genomics Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Genomics Market: Quality Assurance
Figure 5 Global Genomics Market, By Product & Services, 2021
Figure 6 Global Genomics Market, By End-User, 2021
Figure 7 Global Genomics Market, By Geography, 2021
Figure 8 Market Geographical Opportunity Matrix - Global Genomics Market, 2021
Figure 9 Market Positioning of Key Genomics Market Players, 2021
Figure 10 Global Genomics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
Figure 11 Global Genomics Market, By Product & Services, 2021 Vs 2030, %
Figure 12 Global Genomics Market, By End-User, 2021 Vs 2030, %
Figure 13 U.S. Genomics Market (US$ Million), 2020 - 2030
Figure 14 Canada Genomics Market (US$ Million), 2020 - 2030
Figure 15 Rest of North America Genomics Market (US$ Million), 2020 - 2030
Figure 16 UK Genomics Market (US$ Million), 2020 - 2030
Figure 17 Germany Genomics Market (US$ Million), 2020 - 2030
Figure 18 Spain Genomics Market (US$ Million), 2020 - 2030
Figure 19 Italy Genomics Market (US$ Million), 2020 - 2030
Figure 20 France Genomics Market (US$ Million), 2020 - 2030
Figure 21 Rest of Europe Genomics Market (US$ Million), 2020 - 2030
Figure 22 China Genomics Market (US$ Million), 2020 - 2030
Figure 23 Japan Genomics Market (US$ Million), 2020 - 2030
Figure 24 India Genomics Market (US$ Million), 2020 - 2030
Figure 25 Australia Genomics Market (US$ Million), 2020 - 2030
Figure 26 South Korea Genomics Market (US$ Million), 2020 - 2030
Figure 27 Rest of Asia Genomics Market (US$ Million), 2020 - 2030
Figure 28 Brazil Genomics Market (US$ Million), 2020 - 2030
Figure 29 Mexico Genomics Market (US$ Million), 2020 - 2030
Figure 30 Rest of Latin America Genomics Market (US$ Million), 2020 - 2030
Figure 31 GCC Genomics Market (US$ Million), 2020 - 2030
Figure 32 Africa Genomics Market (US$ Million), 2020 - 2030
Figure 33 Rest of Middle East and Africa Genomics Market (US$ Million), 2020 - 2030
List of Tables
Table 1 Global Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 2 Global Genomics Market By Products, 2020-2030, USD (Million)
Table 3 Global Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 4 Global Genomics Market By Services, 2020-2030, USD (Million)
Table 5 Global Genomics Market By End-User, 2020-2030, USD (Million)
Table 6 North America Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 7 North America Genomics Market By Products, 2020-2030, USD (Million)
Table 8 North America Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 9 North America Genomics Market By Services, 2020-2030, USD (Million)
Table 10 North America Genomics Market By End-User, 2020-2030, USD (Million)
Table 11 U.S. Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 12 U.S. Genomics Market By Products, 2020-2030, USD (Million)
Table 13 U.S. Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 14 U.S. Genomics Market By Services, 2020-2030, USD (Million)
Table 15 U.S. Genomics Market By End-User, 2020-2030, USD (Million)
Table 16 Canada Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 17 Canada Genomics Market By Products, 2020-2030, USD (Million)
Table 18 Canada Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 19 Canada Genomics Market By Services, 2020-2030, USD (Million)
Table 20 Canada Genomics Market By End-User, 2020-2030, USD (Million)
Table 21 Rest of North America Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 22 Rest of North America Genomics Market By Products, 2020-2030, USD (Million)
Table 23 Rest of North America Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 24 Rest of North America Genomics Market By Services, 2020-2030, USD (Million)
Table 25 Rest of North America Genomics Market By End-User, 2020-2030, USD (Million)
Table 26 UK and European Union Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 27 UK and European Union Genomics Market By Products, 2020-2030, USD (Million)
Table 28 UK and European Union Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 29 UK and European Union Genomics Market By Services, 2020-2030, USD (Million)
Table 30 UK and European Union Genomics Market By End-User, 2020-2030, USD (Million)
Table 31 UK Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 32 UK Genomics Market By Products, 2020-2030, USD (Million)
Table 33 UK Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 34 UK Genomics Market By Services, 2020-2030, USD (Million)
Table 35 UK Genomics Market By End-User, 2020-2030, USD (Million)
Table 36 Germany Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 37 Germany Genomics Market By Products, 2020-2030, USD (Million)
Table 38 Germany Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 39 Germany Genomics Market By Services, 2020-2030, USD (Million)
Table 40 Germany Genomics Market By End-User, 2020-2030, USD (Million)
Table 41 Spain Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 42 Spain Genomics Market By Products, 2020-2030, USD (Million)
Table 43 Spain Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 44 Spain Genomics Market By Services, 2020-2030, USD (Million)
Table 45 Spain Genomics Market By End-User, 2020-2030, USD (Million)
Table 46 Italy Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 47 Italy Genomics Market By Products, 2020-2030, USD (Million)
Table 48 Italy Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 49 Italy Genomics Market By Services, 2020-2030, USD (Million)
Table 50 Italy Genomics Market By End-User, 2020-2030, USD (Million)
Table 51 France Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 52 France Genomics Market By Products, 2020-2030, USD (Million)
Table 53 France Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 54 France Genomics Market By Services, 2020-2030, USD (Million)
Table 55 France Genomics Market By End-User, 2020-2030, USD (Million)
Table 56 Rest of Europe Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 57 Rest of Europe Genomics Market By Products, 2020-2030, USD (Million)
Table 58 Rest of Europe Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 59 Rest of Europe Genomics Market By Services, 2020-2030, USD (Million)
Table 60 Rest of Europe Genomics Market By End-User, 2020-2030, USD (Million)
Table 61 Asia Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 62 Asia Genomics Market By Products, 2020-2030, USD (Million)
Table 63 Asia Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 64 Asia Genomics Market By Services, 2020-2030, USD (Million)
Table 65 Asia Genomics Market By End-User, 2020-2030, USD (Million)
Table 66 China Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 67 China Genomics Market By Products, 2020-2030, USD (Million)
Table 68 China Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 69 China Genomics Market By Services, 2020-2030, USD (Million)
Table 70 China Genomics Market By End-User, 2020-2030, USD (Million)
Table 71 Japan Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 72 Japan Genomics Market By Products, 2020-2030, USD (Million)
Table 73 Japan Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 74 Japan Genomics Market By Services, 2020-2030, USD (Million)
Table 75 Japan Genomics Market By End-User, 2020-2030, USD (Million)
Table 76 India Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 77 India Genomics Market By Products, 2020-2030, USD (Million)
Table 78 India Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 79 India Genomics Market By Services, 2020-2030, USD (Million)
Table 80 India Genomics Market By End-User, 2020-2030, USD (Million)
Table 81 Australia Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 82 Australia Genomics Market By Products, 2020-2030, USD (Million)
Table 83 Australia Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 84 Australia Genomics Market By Services, 2020-2030, USD (Million)
Table 85 Australia Genomics Market By End-User, 2020-2030, USD (Million)
Table 86 South Korea Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 87 South Korea Genomics Market By Products, 2020-2030, USD (Million)
Table 88 South Korea Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 89 South Korea Genomics Market By Services, 2020-2030, USD (Million)
Table 90 South Korea Genomics Market By End-User, 2020-2030, USD (Million)
Table 91 Latin America Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 92 Latin America Genomics Market By Products, 2020-2030, USD (Million)
Table 93 Latin America Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 94 Latin America Genomics Market By Services, 2020-2030, USD (Million)
Table 95 Latin America Genomics Market By End-User, 2020-2030, USD (Million)
Table 96 Brazil Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 97 Brazil Genomics Market By Products, 2020-2030, USD (Million)
Table 98 Brazil Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 99 Brazil Genomics Market By Services, 2020-2030, USD (Million)
Table 100 Brazil Genomics Market By End-User, 2020-2030, USD (Million)
Table 101 Mexico Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 102 Mexico Genomics Market By Products, 2020-2030, USD (Million)
Table 103 Mexico Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 104 Mexico Genomics Market By Services, 2020-2030, USD (Million)
Table 105 Mexico Genomics Market By End-User, 2020-2030, USD (Million)
Table 106 Rest of Latin America Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 107 Rest of Latin America Genomics Market By Products, 2020-2030, USD (Million)
Table 108 Rest of Latin America Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 109 Rest of Latin America Genomics Market By Services, 2020-2030, USD (Million)
Table 110 Rest of Latin America Genomics Market By End-User, 2020-2030, USD (Million)
Table 111 Middle East and Africa Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 112 Middle East and Africa Genomics Market By Products, 2020-2030, USD (Million)
Table 113 Middle East and Africa Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 114 Middle East and Africa Genomics Market By Services, 2020-2030, USD (Million)
Table 115 Middle East and Africa Genomics Market By End-User, 2020-2030, USD (Million)
Table 116 GCC Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 117 GCC Genomics Market By Products, 2020-2030, USD (Million)
Table 118 GCC Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 119 GCC Genomics Market By Services, 2020-2030, USD (Million)
Table 120 GCC Genomics Market By End-User, 2020-2030, USD (Million)
Table 121 Africa Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 122 Africa Genomics Market By Products, 2020-2030, USD (Million)
Table 123 Africa Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 124 Africa Genomics Market By Services, 2020-2030, USD (Million)
Table 125 Africa Genomics Market By End-User, 2020-2030, USD (Million)
Table 126 Rest of Middle East and Africa Genomics Market By Product & Services, 2020-2030, USD (Million)
Table 127 Rest of Middle East and Africa Genomics Market By Products, 2020-2030, USD (Million)
Table 128 Rest of Middle East and Africa Genomics Market By Instrumentation Technology, 2020-2030, USD (Million)
Table 129 Rest of Middle East and Africa Genomics Market By Services, 2020-2030, USD (Million)
Table 130 Rest of Middle East and Africa Genomics Market By End-User, 2020-2030, USD (Million)
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Merck KGaA
- Danaher Corporation
- GE Healthcare
- BGI
- Illumina Inc.
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.
- QIAGEN
- Myriad Genetics Inc.
- Eurofins Scientific
- 23nMe Inc.
